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The formation of blood in the embryo is dependent
on bone morphogenetic protein (BMP), but how
BMP signaling intersects with other regulators of
hematopoietic development is unclear. Using em-
bryonic stem (ES) cells, we show that BMP4 first in-
duces ventral-posterior (V-P) mesoderm and subse-
quently directs mesodermal cells toward blood fate
by activating Wnt3a and upregulating Cdx and Hox
genes. When BMP signaling is blocked during this
latter phase, enforced expression of either Cdx1 or
Cdx4 rescues hematopoietic development, thereby
placing BMP4 signaling upstream of the Cdx-Hox
pathway. Wnt signaling cooperates in BMP-induced
hemogenesis, and the Wnt effector LEF1 mediates
BMP4 activation of Cdx genes. Our data suggest
that BMP signaling plays two distinct and sequential
roles during blood formation, initially as an inducer of
mesoderm, and later to specify blood via activation
of Wnt signaling and the Cdx-Hox pathway.
INTRODUCTION
Fate-mapping studies of mouse embryogenesis show that differ-
ent mesodermal populations—blood, vasculature, kidney, car-
diac, and skeletal muscle—arise in an orderly manner from dis-
tinct regions of the primitive streak (PS) (Lawson et al., 1991;
Tam and Beddington, 1987). PS cells are patterned in response
to gradients of embryonic morphogens, but how morphogen
combinations specify distinct tissue fates remains poorly under-
stood.
In Xenopus, formation of primitive and definitive blood requires
bone morphogenetic protein (BMP) signaling (Walmsley et al.,
2002). BMPs promote blood formation by specifying mesoderm
during early dorsoventral (DV) patterning. BMP induction during72 Cell Stem Cell 2, 72–82, January 2008 ª2008 Elsevier Inc.early gastrulation causes excess ventral-posterior (V-P) meso-
derm and enhanced hematopoiesis. However, recent data doc-
ument a subsequent role for BMP, showing that manipulation of
the BMP pathway during mid-/late or even post-gastrulation en-
hances blood formation without gross morphological effects
(Kumano et al., 1999; Marom et al., 2005; Schmerer and Evans,
2003). Moreover, specific involvement of the BMP signaling
transducers Smad1 and Smad5 has been recently demon-
strated in zebrafish blood development (McReynolds et al.,
2007). In the mouse, BMP4 deficiency results in early lethality
due to severe mesodermal defects (Winnier et al., 1995). At later
embryonic stages, BMP4 expresses in the vicinity of emerging
blood cells in the murine yolk sac and human AGM (Farrington
et al., 1997; Marshall et al., 2000).
Mesodermal patterning is linked to homeobox-containing Hox
genes, which confer positional identity to tissues emerging from
the PS.Hox genes display an overlapping and graded expression
pattern along the antero-posterior (AP) axis, and specific tissues
express particular ‘‘Hox codes’’ (Favier and Dolle, 1997; Gruss
and Kessel, 1991; Krumlauf, 1994). The caudal (Cdx) family of ho-
meobox genes conveys positional information from morphogens
(e.g., Wnts, FGF, retinoids) to Hox genes during tissue formation
(Lohnes, 2003), and recent studies have demonstrated that
cdx1a and cdx4 specify zebrafish embryonic blood via specific
hox genes (Davidson et al., 2003; Davidson and Zon, 2006).
Embryonic stem (ES) cells are an accessible in vitro model that
can be genetically manipulated and probed with morphogens.
ES cells differentiate into embryoid bodies (EBs) that consist of
tissues from all three germ layers (Keller, 2005), and form blood
cells in an ordered manner corresponding to normal ontogeny
(Keller et al., 1993). The hemangioblast, the earliest hematopoi-
etic precursor cell displaying both hematopoietic and vascular
potential, was first identified in this system and later in mouse
embryos (Choi et al., 1998; Huber et al., 2004).
In this study, we use murine ES cells to explore mesoderm and
hematopoietic specification during mammalian embryogenesis.
We provide evidence that BMP plays a two-step role during
blood specification from ES cells. Initially, BMP mediates DV
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promotes blood specification from preformed mesodermal cells.
In dissecting this second window, we discovered that Wnt
signaling cooperates with BMP to promote blood fate through
activation of the Cdx-Hox genetic pathway. Moreover, the coop-
erative effects of BMP-Wnt on the cdx pathway are evident in
zebrafish, thereby establishing evolutionary conservation of this
pathway for blood development.
Figure 1. Modulation of BMP Signaling and the For-
mation of V-P Mesodermal Cells with Hematopoietic
Potential
(A) BMP4 (25 ng/ml) or Noggin (500 ng/ml) was added to EBs
on day 2.25 of differentiation in SFM or SCM. Phosphorylated
Smad1/5/8 expression was analyzed by western blot on day 3.
Actin, loading control.
(B and C) (B) EBs were differentiated for 2.5 days in SCM, SCM +
BMP4, or SCM + Noggin, and RNA was harvested for quanti-
tative PCR analysis; EBs treated as in (B) were cultured further
in SCM until day 6 and assayed for CD41 expression (flow
cytometry) and CFU formation (C). Data in (B) and (C) are
averages of at least three independent experiments and are
reported as fold change in relative gene expression
normalized to b-actin (B), and % change relative to SCM alone
(C). Error bars represent SEM (B) or SD (C).
RESULTS
Modulating BMP Signaling in Differentiating
EBs
To modulate BMP signaling during ES cell differ-
entiation, we supplemented EB cultures with re-
combinant BMP4 or the BMP antagonist Noggin (Zimmerman
et al., 1996). Phosphorylation of the BMP transducer Smad1/5/
8 and induction of the BMP target gene Id1 (Hollnagel et al.,
1999) were observed upon addition of BMP4 to serum-free dif-
ferentiation medium (SFM), whereas the baseline activation
seen in serum-containing differentiation medium (SCM) was
inhibited by Noggin but further enhanced by supplemental
BMP (Figure 1A and see Figure S1 available online). The inhibitory
Figure 2. BMP Signaling Is Required for V-P Mesoderm Specification to Blood
(A) Schema illustrating two distinct phases (I and II) of BMP action during hematopoietic development from ES cells.
(B–D) Phase II: ES cells were cultured in SCM for 2.25 days, then exposed to BMP4 or Noggin in SFM (B and D) or SCM (C). RNA from ES cells (day 0) and EBs
(days 2–6) was analyzed by quantitative PCR. CFU assays and CD41 flow cytometry were performed on day 6. Time-course data (B) are from one representative
experiment. Data in (C) and (D) are averages of three or more independent experiments and are reported as fold change compared to SCM alone. Error bars
show SEM.Cell Stem Cell 2, 72–82, January 2008 ª2008 Elsevier Inc. 73
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other BMP inhibitor (Chordin; Figure S1A).
BMP Induces V-P Mesoderm from Murine ES Cells
To explore early effects of BMP signaling, we made EBs in SCM
supplemented with BMP4 or Noggin and analyzed RNA (days
2–2.5) for gene expression by quantitative PCR. BMP4 increased
expression of transcription factors characteristic of V-P meso-
derm (Evx1, Mesp1, Cdx1; Dush and Martin, 1992; Huber et al.,
2004; Meyer and Gruss, 1993), while strongly suppressing ante-
rior PS markers (Goosecoid, Cerberus, FoxA2; Belo et al., 1997;
Gadue et al., 2006); Noggin had the opposite effect (Figure 1B).
The panmesendodermal marker brachyury was induced by
BMP4, but only partly suppressed by Noggin (Figure 1B), sug-
gesting that serum factors other than BMP also induce brachyury
(Gadue et al., 2006).
Because antagonizing BMP signaling suppressed V-P meso-
derm, we asked whether it also reduced hematopoiesis. Day
6 EB-derived cells robustly express CD41, the earliest hemato-
poietic antigen (Mikkola et al., 2003), and form hematopoietic col-
onies (CFUs) when assayed in methylcellulose medium. As ex-
pected, manipulation of BMP signaling between days 0–2.5 of
differentiation affected CD41+ and CFU development (Figure 1C).
These data are consistent with prior evidence that hematopoiesis
arises principally from the posterior PS (Huber et al., 2004).
Taken together, our data show that within the first 2.5 days of
EB development, BMP promotes differentiation of ES cells to
brachyury-expressing V-P mesoderm with elevated hematopoi-
etic potential (phase I; Figure 2A), an effect that corresponds to
the early role of BMP in Xenopus DV patterning (Marom et al.,
2005).
BMP Signaling Is Required during Mesoderm
Specification to Hematopoietic Fate
Whereas early BMP4 addition induced brachyury expression
(Figures 1B and 2A), supplementation after day 2.25 did not
Figure 3. BMP Enhances Posterior Blood Island
Formation in Zebrafish
Wild-type (WT; i) and transgenic tg(hsp70:bmp2b; ii and iii) ze-
brafish embryo were examined for gross morphology (a), and
pu.1 and gata1 expression (b and c). Transient bmp2b overex-
pression was induced by heat shock at 75% epiboly (8 hpf) (ii),
or at 50% epiboly (5.5 hpf) (iii).
(phase II in Figure 2A; dotted versus solid line in
Figure 2B). This suggests that, in phase II, BMP
acts in a distinct manner on preformed mesodermal
cells, rather than inducing additional mesodermal
tissue. Consistent with this, the expression of the
mesodermal markers Myogenin, Odd1, and Wnt8a
was not grossly modified by BMP4 during the win-
dow of brachyury expression (until day 4), although
Nkx2.5 expression was suppressed, suggesting
a reduction in heart progenitors (Figure S2A).
To define the role of BMP during hematopoietic
development in phase II, we differentiated EBs in
SCM for 2.25 days and added BMP or Noggin
from days 2.25–6. Addition of BMP4 enhanced, while Noggin
suppressed, hematopoietic CFU and CD41+ cell formation
(Figure 2C). In SFM, where BMP signaling was shown to be
strongly suppressed (Figure 1A and Figure S1A), almost no he-
matopoietic activity could be detected (Figure 2D). Moreover,
supplementation of BMP4 was sufficient to promote blood devel-
opment under these conditions (Figures 2B and 2D).
Taken together, these results suggest that BMP4 acts dis-
tinctly in a second phase on a subset of mesodermal cells that
will undergo hematopoietic differentiation.
BMP Enhances Blood Formation during
Zebrafish Embryogenesis
To explore the relevance of our findings in an accessible animal
model, we overexpressed BMP during zebrafish development,
where V-P mesoderm formation and patterning require BMP
signaling in a dose-sensitive fashion (Hammerschmidt et al.,
1996; Mullins et al., 1996). We hypothesized that BMP induction
during mid- to late gastrulation would promote mesodermal blood
specification without grossly affecting DV patterning. Using
a transgenic zebrafish line that expresses bmp2b under a heat
shock-inducible promoter, we showed that BMP activation at
midgastrulation (75% epiboly; 8 hr post-fertilization [hpf]) induced
only mild ventralization (V2; reduced, but present head structures,
notochord, and somites; Figure 3, iia, and Figure S2B) compared
to embryos induced at the onset of gastrulation (50% epiboly; 5.5
hpf), which were completely ventralized (V5; absent head, noto-
chord, and somites; Figure 3, iiia). Consistent with our hypothesis,
bmp2b induction at midgastrulation strongly expanded the pos-
terior blood islands, as assayed by expression of the blood
markersgata1andpu.1 (Figure 3, iib and 3iic; Figure S3; Davidson
and Zon, 2004). The expression of the BMP-regulated V-P meso-
dermal marker eve1was enhanced by BMP, yet markers of other
V-P mesodermal derivatives (e.g., cdh17; kidney) were relatively
unaffected, suggesting a specific role in hemogenesis (Fig-
ure S2B; Pyati et al., 2005; Hogan et al., 2006).74 Cell Stem Cell 2, 72–82, January 2008 ª2008 Elsevier Inc.
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EBs grown in SCM until day 2.25 were then transferred to SFM or SCM supplemented with recombinant proteins as indicated.
(A and B) Flk1 staining by flow cytometry, day 3.25. Data represent average of three or more independent experiments (A); contour plots from one representative
experiment are shown in (B).
(C) Fifty-thousand unsorted day 3.25 EB cells generated in SFM and proteins as indicated were plated into BL-CFC assays. Data are averages of absolute num-
bers of blast colonies from two independent experiments.
(D) CFU assays from cells generated as in (C) and then further cultured in SFM + BMP4 on gelatinized plates until day 6.
(E) Flk1+ cells isolated from day 3.25 EBs generated in SFM + BMP4, SFM + Noggin, SCM + BMP4, or SCM were cultured on gelatinized plates in SFM + BMP4,
and CFU assays were initiated at day 6. Data are from at least two independent experiments. Error bars represent SD (A and C–E).
(F) dnTCF blocks embryonic blood formation in the zebrafish and cannot be rescued by bmp2b. Transient transgene expression was induced at 75% epiboly
(8 hpf, ii). Wild-type (WT; i), tg(hsp70:dnTCF; ii), and tg(hsp70:dnTCF; hsp70:bmp2b; iii) zebrafish embryos were examined for gross morphology (22 hpf) (a)
and gata1 expression (13.5 hpf) (b).Together, these data suggest that mid- to late gastrulation is
a critical window for BMP-induced specification of hemato-
poietic tissue, and that the role of BMP in blood formation from
V-P mesoderm is conserved in fish and mice.
BMP4 Induces the Formation of Flk1+ Hemangioblasts
Studies in ES cells and recently in zebrafish have defined the he-
mangioblast as the earliest precursor of the blood lineage (Choi
et al., 1998; Huber et al., 2004; Kennedy et al., 2007; Vogeli et al.,
2006; Wang et al., 2004; Zambidis et al., 2005, 2006). In the mu-
rine EB system, the hemangioblast is detected as a Flk1+ Blast
colony-forming cell (BL-CFC) emerging on days 3–3.25 (Choi
et al., 1998). We asked whether BMP signaling was required
for hemangioblast formation, or for their further maturation along
the blood lineage. Days 3–3.25 EBs robustly expressed Flk1
(Figure 4A), and hematopoietic potential segregated with the
Flk1+ compartment, as determined by gene expression andCFU assays (Figures S4A and S4B). Flk1+ cells were also en-
riched for Evx1 and Mesp1, reflective of their posterior mesoder-
mal origin, while (nonhematopoietic) Flk1 cells were enriched in
the anterior PS marker Cerberus (Figure S4B).
To determine the role of BMP signaling in hemangioblast
specification, EBs were differentiated in SCM until day 2.25,
and then cultured another 24 hr in SCM or SFM supplemented
with BMP4 or Noggin. At day 3.25, Flk1+ cells were scored by
flow cytometry and assayed for blast colony (BL-CFC) potential
(Choi et al., 1998; Kennedy et al., 1997). Supplementation of SFM
with BMP4 significantly induced the formation of Flk1+ cells, as
compared to addition of Noggin (Figures 4A and 4B), an effect
also seen in SCM (data not shown). Moreover, BL-CFC and he-
matopoietic CFUs were only detectable from EBs cultured in the
presence of BMP signaling (Figures 4C and 4D). These effects
were even stronger when comparing equal numbers of sorted
Flk1+ cells (Figure 4E). The data indicate that not all Flk1+ cellsCell Stem Cell 2, 72–82, January 2008 ª2008 Elsevier Inc. 75
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BMP signaling plays an essential role in the establishment of
Flk1+ cells with hematopoietic potential.
Having shown that BMP is essential for the formation of Flk1+
cells with hematopoietic potential, we asked whether further
blood differentiation requires sustained BMP signaling. Flk1+
cells generated in BMP4 were cultured for another 3 days in
SFM with Noggin or continued BMP4 supplementation. We de-
tected hematopoietic colonies only from Flk1+ cells continuously
exposed to BMP4 (Figure S4C and data not shown), indicating
a requirement for BMP signaling during the maturation to hema-
topoietic progenitors.
Taken together, our data suggest that BMP is required for
hemangioblast specification from V-P mesoderm, as well as
for further differentiation along the blood lineage.
BMP and Wnt Cooperate during
Hemangioblast Formation
BMP cooperates with Wnt signaling during posterior mesoderm
formation in zebrafish (Szeto and Kimelman, 2004). In the mouse,
BMP and Wnt are coexpressed in the posterior PS (Gadue et al.,
2005). Moreover, Wnt directly regulates Cdx genes (Lohnes,
2003; Pilon et al., 2006, 2007), which are essential for embryonic
blood formation in zebrafish (Davidson et al., 2003; Davidson and
Zon, 2006). We therefore hypothesized that Wnt signaling, per-
haps through activation of Cdx genes, might play a role in meso-
dermal patterning and hematopoietic specification by BMP4. We
first tested whether Wnt is essential for hemangioblast specifica-
tion by adding Wnt-inhibitory proteins (DKK1, SFRP2) to BMP4-
containing SFM from days 2.25–3.25, and assaying for Flk1+
cell formation, BL-CFC, and hematopoietic CFU potential. Inhibi-
tion of Wnt signaling during the window of hemangioblast speci-
fication indeed compromised BMP4-dependent hemogenesis
(Figures 4C and 4D). Flk1+ cells were generated also in the pres-
Figure 5. BMP4 andWnt3a ActivateCdx and Posterior
Hox Genes
(A) EBs differentiated in SCM for 2.25 days were then trans-
ferred to SFM + BMP4 or SFM + Noggin. RNA was harvested
and analyzed by quantitative PCR. Numbers represent fold
change in relative expression levels as compared to undiffer-
entiated ES cells, after normalization to b-actin.
(B) EBs were differentiated in SCM, and proteins were added
at days 2–2.25 (unless otherwise indicated). RNA harvested on
days 3 and 4 was analyzed by quantitative PCR. Numbers rep-
resent fold change in relative expression levels as compared
to expression in SCM, after normalization to b-actin.
Data are from one representative time-course experiment
(A) or averages from three or more independent experiments
(B). Error bars show SEM.
(C) cdx4 expression during zebrafish embryogenesis (11.5 hpf)
in wild-type (i) and Tg(hsp70:bmp2b; ii) embryos. Embryos
were heat shocked at 75% epiboly.
ence of Wnt inhibitors, but at reduced levels (Fig-
ures 4A and 4B). However, even when purified
and assayed in large numbers, hematopoietic activ-
ity was strongly compromised in Flk1+ cells formed
in the absence of BMP (Figure 4E), or in the pres-
ence of Wnt inhibitors (data not shown). A gene ex-
pression analysis performed on Flk1+ cells generated in the pres-
ence of BMP4 plus Wnt inhibitors showed suppression of
hematopoietic markers, and enhancement of other mesodermal
markers (Odd1,WT1; Figure S5). CFU inhibition was achieved by
either DKK1 or SFRP2 (Figure S6A), whereas addition of Wnt3a
failed to rescue hematopoiesis suppressed by Noggin (Figures
4C and 4D). This shows that during V-P mesoderm patterning
to hemangioblast fate, Wnt signaling is necessary, but not suffi-
cient, in the absence of BMP, suggesting that signaling through
both morphogen pathways is required simultaneously. Interest-
ingly, BMP4, but not Wnt supplementation, was sufficient for
blood fate specification in SFM, suggesting that BMP4 may
recruit Wnt to cooperate in blood formation. In support of this
hypothesis, we detected enhanced expression of Wnt3a upon
BMP4 addition (Figure 5A, upper panel), a pattern not seen for
Wnt8a (Figure S2A). Wnt3a induction occurs precisely during
the developmental window (days 2–4) when genetic pathways
mediating blood formation are activated. These data establish
a role for the Wnt pathway during hematopoietic development
from murine ES cells.
We confirmed the requirement of the Wnt pathway during an
equivalent stage of zebrafish embryonic blood formation using
a strain of zebrafish carrying a heat shock-inducible dominant-
negative TCF (hs:dnTCF; Lewis et al., 2004). Wnt inhibition at
75% epiboly profoundly suppressed gata1 expression, an effect
that could not be rescued by simultaneous bmp2b overexpres-
sion in double transgenic fish (hs:dnTCF; hs:bmp2b; Figure 4F).
Cdx and Posterior Hox Genes Are Activated
during Blood Specification
Cdx and posterior Hox genes have been implicated in zebrafish
embryonic hematopoiesis (Davidson et al., 2003; Davidson and
Zon, 2006). Differentiating ES cells strongly express Cdx1 and
Cdx4 during the developmental window of BMP-mediated76 Cell Stem Cell 2, 72–82, January 2008 ª2008 Elsevier Inc.
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Figure 5A). To test the effects of BMP and Wnt signaling on the
Cdx-Hox pathway, we differentiated EBs for 2 days to allow the
formation of mesodermal cells, then supplemented cultures
with relevant morphogens or inhibitors (BMP4, Noggin, activin
A, or Wnt3a), and analyzed RNA by quantitative PCR. Cdx1 and
Cdx4 expression was induced by both BMP4 and Wnt3a (Figures
5A and 5B and Figure S7). BMP4 and Wnt3a caused a synergistic
Cdx upregulation, presumably attributable to enhanced overall
Wnt levels following BMP4 treatment (Figure 5A; Figure S7). Fur-
thermore, BMP4 and Wnt3a induced posterior, and suppressed
anterior, Hox genes of the A and B clusters (Figures 5A and 5B),
while Noggin effected the opposite (Figures 5A and 5B). High
doses of activin A also suppressed posterior Hox genes (Fig-
ure 5B), matching our observation showing suppression of
hematopoiesis by this condition (data not shown).
BMP andWnt Regulate cdx4 Expression in the Zebrafish
To explore whether the upstream regulation of theCdx-Hoxpath-
way by BMP-Wnt is conserved between fish and mouse, we stud-
ied the effects of conditional bmp2b overexpression on cdx gene
expression in zebrafish embryos. Like their mammalian counter-
parts, zebrafish cdx genes are expressed in successive waves
preceding the onset of scl expression (Davidson et al., 2003; Fig-
ures S3 and S8). cdx4 mutants display severe defects in embry-
onic blood formation, while cdx1a morphants display a milder
phenotype (Davidson and Zon, 2006). Conditional activation of
bmp2b during midgastrulation resulted in a widened expression
domain of cdx4 in the region of developing blood precursor cells
(Figure 5C). This preceded the upregulation of the hematopoietic
markers pu.1 and gata1 that express at a later stage of develop-
ment (Figure S3; Davidson and Zon, 2004). Conversely, cdx4 ex-
pression was severely reduced following Wnt inhibition by heat
shock-inducible dnTCF (Figure S6D), consistent with the altered
hematopoietic phenotype observed for this condition (Figure 4F).
These data suggest an evolutionarily conserved role for BMP and
Wnt signaling during cdx gene regulation.
Wnt Signaling Mediates BMP-Dependent
Cdx Gene Activation
We hypothesized that Wnt signaling might be an intermediate
step between BMP4 and activation of the Cdx-Hox pathway in
blood development. To address this question, we performed
chromatin immunoprecipitation (ChIP) on day 3 EB-derived cells
treated with either BMP4 or Noggin, and assayed the associa-
tion of the Wnt effector LEF1 with Cdx regulatory regions. As
a positive control, we used a known LEF1-responsive fragment
in the regulatory region of the brachyury gene (Figure 6A). It has
been shown that Wnt3a signaling and LEF1 are required for the
maintenance, but not initiation, of brachyury expression during
mouse embryogenesis (Galceran et al., 2001). We found a mod-
est but reproducible association of LEF1 with a proximal Cdx1
promoter fragment, which was modulated in the presence of
BMP signaling (Figure 6A). No LEF1 binding was detected at
a distal fragment of the Cdx1 promoter or in regulatory regions
of Cdx4 (Figure 6A and data not shown). We could not detect
association of phosphorylated forms of the BMP-specific tran-
scription factors Smad1/5/8 with Cdx regulatory regions, sug-gesting that the BMP effect on Cdx genes is indirect (data not
shown).
To corroborate these results, we generated luciferase reporter
gene constructs containing a minimal 0.7 kb Cdx1 promoter
fragment, which has been shown in vivo to reflect the endoge-
nous expression pattern of the Cdx1 gene (Lickert and Kemler,
2002). This promoter fragment was sufficient to confer activation
of the luciferase reporter upon addition of BMP4 or Wnt3a (Fig-
ure 6B). Addition of the Wnt inhibitor SFRP2 markedly decreased
the response of the Cdx1 promoter to BMP4 and reduced its
basal activity, while treatment with Noggin had no effect on the
promoter activation by Wnt3a or on basal activity levels
Figure 6. BMP4 Activation of Cdx1 Is Mediated through the Wnt
Pathway
(A) ChIP of day 3 EB-derived cells, preincubated with BMP4 or Noggin, shows
BMP-modulated LEF1 binding to the proximal Cdx1 promoter. Relative
enrichment refers to enrichment of each fragment relative to a GAPDH control
fragment.
(B and C) Luciferase reporter gene assays to analyze the relationship between
BMP and Wnt signaling during the activation of Cdx1. (B) A 0.7 kb Cdx1 pro-
moter fragment was sufficient to confer responsiveness to BMP4 and
Wnt3a. Inhibition of Wnt signaling by SFRP2 decreased the activation of the
Cdx1 promoter by BMP4, while inhibition of BMP by Noggin had no effect
on the induction of the promoter by Wnt3a. (C) Point mutation of LEF1 binding
sites in the Cdx1 promoter (pGL3-X1-TBE3/4mut) suppressed the basal
activity of the Cdx1 promoter and its induction by BMP4 and Wnt3a.
(A–C) Shown are data from two independent experiments; error bars
show SEM.Cell Stem Cell 2, 72–82, January 2008 ª2008 Elsevier Inc. 77
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(A) Inducible Cdx1, Cdx4, and Hoxa9 ES cells were differentiated in SCM until day 2.25 (unless indicated otherwise), then transferred to medium supplemented
with proteins and/or doxycycline, as indicated. CFU assays were initiated on day 6. Cultures in SCM were used as controls to calculate relative CFU formation
(%CFU). Numbers reflect percentages of CFU numbers from experimental conditions relative to numbers counted in control (SCM) cultures.
(B) EBs were differentiated in SCM until day 2.25, then exposed to doxycycline to induce Cdx expression. Samples with and without doxycycline were collected
4 hr, 8 hr, and 16 hr later. Shown are fold changes in relative expression levels as compared to control samples cultured without doxycycline, after normalization
to b-actin.
(C) Panel shows quantitative PCR analysis performed under the conditions described above to assayCdx4 induction byCdx1 after 16 hr of doxycycline exposure,
with or without simultaneous inhibition of Wnt signaling by DKK1 and SFRP2.Cdx4 induction without Wnt inhibitors was defined as 100%, and induction levels in
the presence of Wnt inhibitors were calculated accordingly.
Data shown are averages of at least three (A), or two (B and C), independent experiments. Error bars represent SD (A) and SEM (B and C).(Figure 6B; Figure S6B). Moreover, point mutations within LEF1
binding sites of the Cdx1 promoter inhibited its basal activity
and abrogated its response to BMP4 or Wnt3a (Figure 6C),
further demonstrating that BMP4 activates the Cdx1 promoter
via LEF1 and the Wnt pathway.
Conditional Expression of Cdx-Hox Genes Bypasses
Morphogens
To determine whether Cdx-Hox genes mediate BMP/Wnt-medi-
ated blood specification, we asked whether enforced expression
ofCdx1 orCdx4might rescue blood formation when BMP signal-
ing is blocked. We used ES cells with conditionally inducibleCdx4
(iCdx4; Davidson et al., 2003; Wang et al., 2005), or Cdx1 (iCdx1;
S.M.-F. and I.H.J., unpublished data). Inducible ES cells were
differentiated as EBs in SCM until day 2.25 and then transferred
to SFM or SCM supplemented with Noggin, which inhibits hema-
topoietic development. Expression of Cdx1 or Cdx4 from days
2.25–6 rescued hematopoietic CFU formation, bypassing the
BMP4 requirement during this phase (Figure 7A). Cdx1 had a
stronger effect, fully rescuing CFU formation in all compartments
(erythroid, myeloid, and GEMM), while Cdx4 showed a slight de-
ficiency in the rescue of erythroid CFUs. These data indicate that
activation of either Cdx1 or Cdx4 is sufficient to establish hema-
topoietic fate in the absence of BMP signaling. Induced expres-78 Cell Stem Cell 2, 72–82, January 2008 ª2008 Elsevier Inc.sion of Cdx genes did not rescue the hematopoietic defect of
EBs exposed to Noggin from the onset of differentiation (day 0;
Figure 7A), consistent with a phase II-specific rescue effect by
the Cdx-Hox pathway in blood formation.
In the zebrafish, overexpression of hoxa9a partially rescues
blood formation in cdx mutants (Davidson et al., 2003; Davidson
and Zon, 2006). To explore this effect in murine ES cells, we
generated inducible Hoxa9 ES cells (iHoxa9). Induction was con-
firmed by protein and gene expression (Figures S9A and S9B).
During days 2.25–6 of EB development, Hoxa9 induction en-
hanced the formation of myeloid colonies (Figure S9C), and
activation when BMP signaling was blocked partially rescued
hematopoiesis (Figure 7A and Figure S9C). The limited rescue
may reflect the fact that additional Hox genes (which Cdx1 and
Cdx4 induce) are required for robust blood formation. Consistent
with this, suppression of single hox genes in zebrafish does not
phenocopy the strong hematopoietic defects observed in cdx
mutants (Davidson et al., 2003; L.I.Z. and A.J.D., unpublished
data).
Wnt Signaling Mediates Cdx Crossregulation
We asked whether Cdx genes are strictly downstream of BMP/
Wnt, or may rescue blood development by inducing morphogen
expression. We exposed days 2–2.25 EBs from iCdx1 and iCdx4
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hr, and 16 hr for quantitative gene expression analysis. Condi-
tional Cdx gene expression failed to induce BMP4 or Wnt8a,
but did stimulate Wnt3a expression (Figure 7B). Furthermore,
Cdx1 andCdx4 positively crossregulated each other (Figure 7B).
Cdx1 was a more potent inducer of Cdx4 (Figure 7B), possibly
explaining its stronger effect in functional assays (Figure 7A;
S.M-F., C.L., I.H.J., S.S., J. Shea, Y. Wang, M. Philitas, and
G.Q.D., unpublished data). Because Cdx1 upregulated Wnt3a,
we asked whether Cdx crossregulation was mediated by Wnt.
Indeed, simultaneous addition of Wnt inhibitors reduced the ac-
tivation of Cdx4 by Cdx1 (Figure 7C). Matching these molecular
results, functional experiments showed slightly lower numbers of
hematopoietic CFUs in Cdx1 rescue experiments performed in
the presence of SFRP2 and DKK1, as compared to cultures with-
out Wnt inhibitors (data not shown).
DISCUSSION
BMP4 enhances hematopoietic differentiation from ES cells
(Chadwick et al., 2003; Li et al., 2001), but the genetic pathways
linking BMP action to blood fate specification have not been de-
fined. In this study, we have uncovered sequential roles for BMP
in the induction of V-P mesoderm and the specification of hema-
topoietic fate. We discovered a previously unsuspected coordi-
nation between BMP4 and Wnt3a signaling in embryonic hema-
topoiesis and linked these morphogens directly to Cdx and Hox
genes. Moreover, we have demonstrated conservation of these
pathways in zebrafish. Together, our data provide a mechanistic
framework that links embryonic morphogens and a central
genetic pathway for blood development.
Our work builds upon prior studies that demonstrated the action
of BMP4 on blood development. Using Scl+/CD4 knockin ES cells,
Park et al. showed that BMP4 induces Flk1+ and Scl+ cells under
serum-free conditions (Park et al., 2004). More recently, ectopic
expression of the BMP transducer Smad1 was shown to expand
hemangioblast populations derived from murine ES cells, sug-
gesting a role for BMP signaling during patterning and/or survival
and proliferation of these cells (Zafonte et al., 2007). At later
stages, BMP signaling activates hematopoietic transcription fac-
tors such asGata2andRunx1, promoting the maturation along the
blood lineage (Lugus et al., 2007; Pimanda et al., 2007).
Consistent with data from Xenopus embryogenesis, we have
identified distinct phases where BMP is required during hemato-
poietic development from mouse ES cells and have validated
these results in another model vertebrate, the zebrafish. During
the first 2 days of EB development, BMP promotes the formation
of V-P mesoderm. Subsequently, BMP is essential for the forma-
tion of Flk1+ hemangioblasts and their maturation into hemato-
poietic progenitors. In support of this model, in vivo studies in
mouse embryos have found that ablation of BMP4 from the on-
set of development causes gross mesoderm defects, presum-
ably because DV patterning is disrupted (Winnier et al., 1995).
BMP4 is expressed later in defined anatomical sites of blood for-
mation (yolk sac mesoderm and AGM; Farrington et al., 1997;
Marshall et al., 2000). Conditional Smad4 inactivation in Flk1+
cells significantly compromised murine blood formation (Park
et al., 2006), further implicating the BMP/TGF-b/activin pathway
in murine blood specification.During embryonic development, positional information is
translated from morphogen pathways to Hox genes, which by
virtue of their restricted expression domains confer positional
identity along the AP axis. In zebrafish, cdx genes have been
identified as essential regulators of embryonic blood formation,
controlling the ‘‘hox code’’ responsible for hematopoietic identity
(Davidson et al., 2003; Davidson and Zon, 2006). Cdx-deficient
zebrafish embryos lack embryonic blood and display aberrant
hox gene expression (Davidson et al., 2003; Davidson and Zon,
2006). In contrast to zebrafish,Cdx1 andCdx4 single and double
null mutant mice manifest no gross hematopoietic defects (van
Nes et al., 2006), perhaps due to functional redundancy among
the three mammalian Cdx genes (Cdx1, 2, and 4). However, we
have observed reduced hematopoiesis in Cdx1 null and Cdx4
null murine ES cells differentiated in vitro, suggesting that com-
pensatory responses occur within the developing mouse embryo
that are absent in vitro (Y. Wang and G.Q.D., unpublished data).
A null mutant of all three murine Cdx genes has not been re-
ported and is technically challenging becauseCdx2 null embryos
die early due to trophectodermal defects. Although there are dif-
ferences in the degree of severity of cdx mutants in the zebrafish
and the mouse, we show that BMP and Wnt signaling play a con-
served role in promoting Cdx activation and blood development
in both species.
Hemangioblasts have been isolated from the posterior PS of
mouse embryos (Huber et al., 2004), a region of high BMP4,
Wnt3a, and Cdx expression (Gadue et al., 2005; Ikeya and
Takada, 2001). Wnt regulates Cdx genes during mouse (Ikeya
and Takada, 2001) and zebrafish embryogenesis (Shimizu et al.,
2005), and Wnt3a mouse mutants and wnt3a/wnt8 morphant ze-
brafish embryos display caudal phenotypes reminiscent of cdx1/
cdx4 mutants. Recently, Wnt3a has been shown to be a direct
regulator of murine Cdx1 and Cdx4 (Pilon et al., 2006, 2007). We
have shown that BMP4 induces Wnt signaling, which is required
for Cdx1 and Cdx4 activation and for hemangioblast specifica-
tion, and that overexpression of either Cdx1 or Cdx4 in the
absence of BMP4 signaling can functionally rescue blood devel-
opment from mouse ES cells. We also detected Wnt-mediated
crossregulation between Cdx1 and Cdx4. Cdx1 autoregulation
has been described, and previous reports have identified physical
interactions and documented synergy between Cdx1 and LEF1
(Beland et al., 2004). Emerging data from other laboratories indi-
cate that the regulation of downstream Hox genes by Cdx genes
is also often associated with Wnt responsiveness, supporting the
finding that Wnt signaling plays a major role in regulating the
Cdx-Hox pathway (Robb Krumlauf, personal communication).
Although we propose a linear BMP-Wnt-Cdx-Hox pathway,
our data also imply that BMP has non-Wnt-dependent modes
of promoting blood formation, as Wnt3a was not itself sufficient
to rescue blood formation in the absence of BMP signaling. En-
forced Cdx expression did rescue hematopoietic differentiation,
but it is possible that high levels of Cdx gene expression in our
conditional system may override a requirement for BMP-depen-
dent cofactors.
Recent data in the adult zebrafish have established that BMP
and Wnt regulate cdx4, and that both can stimulate the regener-
ation of the hematopoietic system in an adult zebrafish injury
model (T.V.B. and L.I.Z., unpublished data). Given the evolution-
ary conservation of these pathways from fish to mice, weCell Stem Cell 2, 72–82, January 2008 ª2008 Elsevier Inc. 79
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exploited to direct the differentiation of human ES cells into
blood. Furthermore, as shown by recent studies implicating
Cdx genes in leukemia, embryonic studies may provide valuable
insights into pathways activated in human disease (Bansal et al.,
2006; Scholl et al., 2007).
EXPERIMENTAL PROCEDURES
ES Cell Culture and Differentiation
Murine ES cells were cultured and differentiated as described (Kyba et al.,
2002). Serum-containing differentiation medium (SCM) contained 15% fetal
calf serum (Stem Cell Technologies). For SFM, fetal calf serum was substituted
with 15% knockout serum replacement medium (GIBCO), and 100 ng/ml
hFlt3L, 100 ng/ml hSCF, 80 ng/ml mVEGF, and 50 ng/ml basic FGF (all from
Peprotech) were added. Proteins (R&D Systems) were used as follows (unless
otherwise indicated): 25 ng/ml (SFM), 50 ng/ml (SCM) BMP4; 250 ng/ml (SFM),
500 ng/ml (SCM) Noggin; 50 ng/ml Wnt3a; 200 ng/ml DKK1; 1 mg/ml SFRP2;
100 ng/ml activin A; and 3.5 mg/ml Chordin. For 2D culture assays, day 3
EBs were dissociated to single cells by 0.25% trypsin (Invitrogen) and plated
at a density of 1 3 105 cells/cm2 in tissue culture dishes precoated with 1%
gelatin. After 3 days of 2D culture, cells were harvested by trypsin and plated
into CFU assays.
Inducible Hoxa9 ES Cells
Hoxa9 cDNA (Krivtsov et al., 2006) was subcloned into plox and electroporated
with pSALK-Cre into 43 106 AinV15 ES cells (ATCC; Kyba et al., 2002). Resis-
tant colonies selected with G418 (400 mg/mL, Sigma) were expanded, and in-
ducible gene and protein expression was confirmed by quantitative RT-PCR
and western blot.
Flow Cytometry and Cell Sorting
EB cells were stained with PE-conjugated anti-Flk1 or anti-CD41 (BD Pharmin-
gen). Propidium iodide was added to exclude dead cells. Flow cytometry was
performed on a FACSCalibur from Becton Dickinson. Flk1+ and Flk1 cells
were isolated with magnetic anti-PE microbeads (Miltenyi Biotech). Purity
was routinely >90%.
Colony Assays
Hematopoietic progenitor colony assays were performed as described (Perlin-
geiro et al., 2003), and CFUs were scored based on gross morphology:
erythroid (E), myeloid (M), granulocyte-macrophage (GM), erythroid-granulo-
cyte-monocyte-macrophage-megakaryocytic multilineage (GEMM). Blast
cell colonies (BL-CFC) were assayed as described (Choi et al., 1998).
Gene Expression Analysis
Total RNA was isolated using RNA-Stat 60 (TelTest) and treated with DNase I
(Ambion), and cDNAs were prepared according to the manufacturer’s instruc-
tion (Invitrogen). Real-time PCR was performed with SYBR green reagent kits
(Stratagene) on an MX3000P Stratagene PCR machine. Primer sequences
were used as published (Ernst et al., 2004), or as listed in Table S2A.
Western Blot
Phosphorylated Smad1/5/8 was detected using a rabbit antibody (Chemicon),
Hoxa9 expression was detected with rabbit antisera (Upstate), and actin was
detected via a mouse antibody (BD Transduction Laboratories). Secondary
antibodies used were horseradish peroxidase coupled anti-rabbit or anti-
mouse antisera (GE Healthcare).
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed as described, using day
3.1 EBs preincubated with BMP4 (50 ng/ml) or Noggin (250 ng/ml) in SFM (Or-
lando et al., 1997; Weinmann and Farnham, 2002). Ten micrograms anti-LEF1
antibody (H-70, Santa Cruz Biotechnology) was used per sample, and immu-
noprecipitated DNA was analyzed by real-time PCR. Relative enrichments
represent abundance of precipitated material compared with input control,80 Cell Stem Cell 2, 72–82, January 2008 ª2008 Elsevier Inc.followed by normalization to a fragment within the GAPDH gene. Primer
sequences are listed in the Table S1B.
Luciferase Reporter Gene Assays
A 0.7 kb Cdx1 promoter sequence (Lickert and Kemler, 2002) amplified from
genomic DNA using primers LUCI1 was cloned into the XhoI site of pGL3 basic
(Promega), generating the pGL3-X1-0.7 kb construct. The mapped LEF/TCF
binding sites at positions113 and82 (Lickert et al., 2000) were mutated us-
ing the Stratagene QuikChange site-directed mutagenesis kit. Sequences are
listed in Table S1C. Constructs were verified by sequencing. Day 2.1 EB-de-
rived cells were transferred to 24-well plates and transfected using Lipofect-
amine 2000 (Invitrogen). For each sample, transfections were carried out in
triplicate, using 800 ng of reporter plasmid together with 8 ng pRLSV40 Renilla
luciferase control vector (Promega). Luciferase expression was assessed 24 hr
later using the Dual-Luciferase Reporter Assay System (Promega).
Zebrafish Embryo Experiments
Zebrafish were maintained and bred as described (Solnica-Krezel et al., 1994).
Wild-type Ab and Tg(hsp70:bmp2b) or Tg(hsp70:dnTCF) were used. To induce
bmp2b or dnTCF expression, the embryos were incubated in a water bath at
36C for 15 min. Embryos were scored for gross morphology, fixed overnight
at 4C in 4% paraformaldehyde, and processed by whole-mount in situ hybrid-
ization (Davidson et al., 2003). Digoxygenin-labeled antisense RNA probes
were synthesized using a DIG RNA labeling kit (SP6/T7; Roche). For gene
expression analysis, five to eight wild-type Ab embryos were collected at the
designated stage. Primer sequences are listed in Table S2D.
Statistical Analysis
Student’s t test was used for statistical analysis. P values were indicated in
Table S1 and in the figures as follows: *p = 0.05–0.01, **p = 0.01–0.001, and
***p < 0.001. Error bars show standard error (SEM) or standard deviation
(SD). Results regarding statistical significance (p value) are listed in Table S1.
Supplemental Data
Supplemental Data include nine figures and two tables and can be found
with this article online at http://www.cellstemcell.com/cgi/content/full/2/1/
72/DC1/.
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